NZD14.88 0.2 1.6%
Last Trade - 3:59am
| Market Cap | £3.83bn |
| Enterprise Value | £4.95bn |
| Revenue | £230.6m |
| Position in Universe | 86th / 1832 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 227.1 | 261.1 | 289.2 | 342.5 | 382.3 | 423.9 | 578.5 | 646.4 | +13.3% | ||
| +24.1 | +26.3 | +16.7 | +8.8 | -16.0 | -18.9 | -5.10 | +20.7 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Ryman Healthcare Limited develops, owns and operates integrated retirement villages, resthomes and hospitals for the elderly people. The Company offers various living and care options, including independent living, assisted living, resthome, hospital and dementia. The independent townhouses and apartments are occupied by residents wishing to retain a level of independence. The Company's Assisted Living offers a range of services, including meals, housekeeping services, morning and afternoon tea, shopping trips and the resort style facilities offered by the village. Resthome and Hospital level care in its Village offers residents in clinical care. The Company offers a specialized care unit for residents. The Company's Villages include residents requiring short-term care, respite care and day care. The Company also offers Day Care program for those just needing assistance during the day. The Company operates in New Zealand with various operations in Australia.
| Last Annual | March 31st, 2020 |
| Last Interim | September 30th, 2020 |
| Incorporated | May 8, 1987 |
| Public Since | June 25, 1999 |
| No. of Shareholders: | n/a |
| No. of Employees: | 1,400 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | FTSE Developed Asia Pacific , FTSE Developed Asia Pacific Ex Japan , |
| Exchange | New Zealand Stock Exchange |
| Shares in Issue | 497,288,756 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 92 Russley Road,PO Box 771, CHRISTCHURCH, 8140, New Zealand |
| Web | https://www.rymanhealthcare.co.nz/ |
| Phone | +64 3 3664069 |
| Contact | Michelle Perkins (IR Contact Officer) |
| Auditors | Deloitte LLP |
As of 3:59am, shares in Ryman Healthcare are trading at NZD14.88, giving the company a market capitalisation of £3.83bn. This share price information is delayed by 15 minutes.
Shares in Ryman Healthcare are currently trading at NZD14.88 and the price has moved by -7.86% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Ryman Healthcare price has moved by -10.56% over the past year.
Of the analysts with advisory recommendations for Ryman Healthcare, there are there are currently 0 "buy" , 3 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Ryman Healthcare is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Ryman Healthcare is scheduled to issue upcoming financial results on the following dates:
The Ryman Healthcare dividend yield is 0.98% based on the trailing twelve month period.
Last year, Ryman Healthcare paid a total dividend of 0.14, and it currently has a trailing dividend yield of 0.98%. Looking ahead, Ryman Healthcare has not announced an ex-dividend date yet.
Ryman Healthcare has yet to annouce their ex-dividend date. The historic dividend yield on Ryman Healthcare shares is currently 0.98%.
To buy shares in Ryman Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Ryman Healthcare are currently trading at NZD14.88, giving the company a market capitalisation of £3.83bn.
Here are the trading details for Ryman Healthcare:
Based on an overall assessment of its quality, value and momentum, Ryman Healthcare is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Ryman Healthcare are currently priced at NZD14.88. At that level they are trading at 4.21% premium to the analyst consensus target price of 0.00.
Analysts covering Ryman Healthcare currently have a consensus Earnings Per Share (EPS) forecast of 0.502 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ryman Healthcare. Over the past six months, the relative strength of its shares against the market has been -2.34%. At the current price of NZD14.88, shares in Ryman Healthcare are trading at 3.71% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ryman Healthcare PE ratio based on its reported earnings over the past 12 months is 25.37. The shares are currently trading at NZD14.88.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ryman Healthcare's management team is headed by:
Here are the top five shareholders of Ryman Healthcare based on the size of their shareholding:
